4//SEC Filing
BLUHM ANDREW G 4
Accession 0000899243-17-022122
CIK 0001434647other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 1:30 PM ET
Size
16.5 KB
Accession
0000899243-17-022122
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Transactions
- Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+200$650→ 1,652,774 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+186,831$607,574→ 1,652,574 total - Purchase
Common Stock, par value $0.0001
2017-09-14$3.30/sh+138,857$458,603→ 1,791,631 total
DSC Advisors, L.P.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+186,831$607,574→ 1,652,574 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+200$650→ 1,652,774 total - Purchase
Common Stock, par value $0.0001
2017-09-14$3.30/sh+138,857$458,603→ 1,791,631 total
DSC Advisors, L.L.C.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001
2017-09-14$3.30/sh+138,857$458,603→ 1,791,631 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+186,831$607,574→ 1,652,574 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+200$650→ 1,652,774 total
BLUHM ANDREW G
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001
2017-09-14$3.30/sh+138,857$458,603→ 1,791,631 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+186,831$607,574→ 1,652,574 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+200$650→ 1,652,774 total
DSC Managers, L.L.C.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+186,831$607,574→ 1,652,574 total - Purchase
Common Stock, par value $0.0001
2017-09-13$3.25/sh+200$650→ 1,652,774 total - Purchase
Common Stock, par value $0.0001
2017-09-14$3.30/sh+138,857$458,603→ 1,791,631 total
Footnotes (4)
- [F1]The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. ("DSCA), the investment manager of Delaware Street Master Fund, L.P. (the "Fund"), DSC Managers, L.L.C. ("DSCM"), the general partner of the Fund, DSC Advisors, L.L.C. ("DSCA LLC"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the "Common Stock"), of KemPharm, Inc. (the "Issuer") purchased by the Fund. Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership.
- [F2]The Fund holds the shares of Common Stock directly. DSCA serves as the investment manager to the Fund. DSCA LLC serves as the general partner of DSCA. DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund. Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities.
- [F3]The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day. The range of purchase prices was $3.15 to $3.30. The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F4]The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day. The range of purchase prices was $3.25 to $3.35. The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001083033
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 1:30 PM ET
- Size
- 16.5 KB